Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / NEA Management Company, LLC
Form 13F · Q2 2026

NEA Management Company, LLC

CIK 1512848申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$15.9亿
申报组合市值
26
持仓数量
12
Quarters on record
Top 50
持仓数量

NEA Management Company, LLC——持仓

共 26 个持仓中的前 26 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1TRVI Trevi Therapeutics Inc13.2M+0.0%$2.5亿15.5%
2MBX Mbx Biosciences Inc3.6M+0.0%$2.0亿12.6%
3GLUE Monte Rosa Therapeutics Inc7.7M+0.0%$1.9亿11.7%
4CELC Celcuity Inc1.7M−25.2%$1.8亿11.3%
5SGP Spyglass Pharma Inc7.4M+0.0%$1.6亿10.4%
6SVRA Savara Inc24.5M+0.0%$1.5亿9.5%
7ZBIO Zenas Biopharma Inc4.0M+0.0%$1.0亿6.4%
8COUR Coursera Inc12.9M+0.0%$7257万4.6%
9AUPH Aurinia Pharmaceuticals Inc4.0M+0.0%$6737万4.2%
10CRSP Crispr Therapeutics Ag1.1M+0.0%$5773万3.6%
11ORIC Oric Pharmaceuticals Inc4.1M+0.0%$4460万2.8%
12PHAT Phathom Pharmaceuticals Inc2.0M+0.0%$2127万1.3%
13KRRO Korro Bio Inc1.3M+0.0%$1711万1.1%
14XFOR X4 Pharmaceuticals, Inc.3.2M+0.0%$1510万1.0%
15CSBR Champions Oncology Inc1.7M+0.0%$1056万0.7%
16NKTX Nkarta Inc3.6M+0.0%$1010万0.6%
17CVRX Cvrx Inc2.0M−3.5%$1005万0.6%
18BDTX Black Diamond Therapeutics I4.4M+0.0%$823万0.5%
19KPTIQ Karyopharm Therapeutics Inc576,780—$564万0.4%
20IVA Inventiva Sa1.5M+0.0%$553万0.3%
21LONA Leonabio Inc464,398+0.0%$427万0.3%
22SNTI Senti Biosciences, Inc.3.8M+0.0%$415万0.3%
23MRKR Marker Therapeutics Inc1.6M+0.0%$239万0.2%
24OKUR Onkure Therapeutics Inc478,548+0.0%$218万0.1%
25IMA Imagenebio Inc50,005+0.0%$30万0.0%
26GOSS Gossamer Bio Inc1.0M+0.0%$16万0.0%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。